Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

516
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
516
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

295
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
295
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

358
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
358
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

430
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
430
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

647
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
647
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

433
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
433

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Fat-Fraction Quantification Using Three-Point Dixon Technique in Duchenne Muscular Dystrophy and Its Correlation With Clinical Progression and Genotypic Characteristics: A Single Centre One-Year Prospective Study.

Muscle & nerve·2026
Same author

Regional Cerebral Blood Flow Patterns on ASL in Subacute Sclerosing Panencephalitis: Quantitative Analysis and Clinical Correlation.

AJNR. American journal of neuroradiology·2026
Same author

Setting research priorities around the impact of COVID-19 control measures on people with dementia and caregivers living at home: A 14-country perspective.

Journal of Alzheimer's disease : JAD·2026
Same author

GABAergic dysfunction in Parkinson's disease: insights from in vivo proton magnetic resonance spectroscopy.

NPJ Parkinson's disease·2026
Same author

Beyond gross total resection (GTR): Deep peritumoral radiomics for predicting overall survival (OS) and O6-methylguanine-DNA-methyltransferase promoter methylation (MGMTpm) status in glioblastoma multiforme.

Neuroradiology·2026
Same author

Imaging of Central Nervous System Disorders of Protein Folding.

Seminars in roentgenology·2026

関連する実験動画

Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K

臨床症状

Sarath Govindaraj1, Shivam Mishra1, Suvarna Alladi2

  • 1National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
まとめ
この要約は機械生成です。

アルツハイマー病や血管性認知症を含む認知症サブタイプと血管性危険因子が関連している。高血圧や糖尿病などの病状の早期特定と介入は、認知症のリスク管理に不可欠である。

キーワード:
認知症血管性危険因子アルツハイマー病血管性認知症早期介入南インド

さらに関連する動画

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

関連する実験動画

Last Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

科学分野:

  • 神経学;老年医学;公衆衛生

背景:

  • 世界的な認知症の有病率は上昇しており、早期診断と危険因子の特定が必要である。修正可能な危険因子を標的とした介入は、認知症の影響を軽減するための鍵である。認知症サブタイプに対する血管性危険因子の影響を理解することは、南インドの人口にとって極めて重要である。

研究 の 目的:

  • 認知症サブタイプの臨床的・画像的プロファイルと血管性危険因子との関連を調査する。人口統計学的および臨床的データと画像所見を南インドのコホートで分析する。アルツハイマー病、血管性認知症、その他の認知症タイプにおける血管性危険因子の影響を区別する。

主な方法:

  • 三次ケア病院の認知症疾患クリニックの登録簿から300人の認知症患者の後ろ向き分析を行った。収集されたデータには、血管性危険因子(高血圧、糖尿病、脂質異常症、喫煙、アルコール、心血管疾患)、人口統計学的情報、および臨床評価(ACE III、CDRスケール)が含まれていた。脳画像データ(萎縮、白質高信号、微小出血)を視覚的評価スケールを用いて評価した。

主要な成果:

  • アルツハイマー病(44%)が最も一般的で、次いで血管性認知症(23.3%)であった。高血圧は混合性(72.4%)および血管性認知症(70%)で高頻度であった。血管性認知症は、糖尿病(47.1%)、喫煙(42.9%)、アルコール乱用(12.9%)の有病率が高かった。白質高信号と微小出血は、血管性認知症およびその他のサブタイプで顕著であった。

結論:

  • 血管性危険因子は、神経変性認知症と血管性認知症の両方と有意に関連している。血管性危険因子の早期特定と標的化された介入は、認知症の予防と管理に不可欠である。動的な相互作用を理解し、多様な認知症サブタイプにわたる治療戦略を洗練するためには、さらなる縦断的研究が必要である。